John W. King

1.9k total citations
59 papers, 749 citations indexed

About

John W. King is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, John W. King has authored 59 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in John W. King's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). John W. King is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). John W. King collaborates with scholars based in United States, South Africa and Spain. John W. King's co-authors include Steven A. Conrad, George A. DeVault, Stephen T. Brown, Burton C. West, Joel Schulman, Chanping Liang, Michael D. Landreneau, Michael S. Rohr, John C. McDonald and Arnold Oberle and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

John W. King

55 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John W. King United States 17 360 186 178 88 87 59 749
A. Boibieux France 20 593 1.6× 77 0.4× 571 3.2× 32 0.4× 86 1.0× 95 1.1k
Olivier Lortholary France 15 579 1.6× 112 0.6× 491 2.8× 122 1.4× 19 0.2× 46 1.3k
Kjell B. Hellum Norway 18 787 2.2× 694 3.7× 308 1.7× 84 1.0× 161 1.9× 43 1.4k
John J. Stern United States 17 590 1.6× 67 0.4× 460 2.6× 43 0.5× 102 1.2× 38 1.3k
Ronald E. Keeney United States 21 1.4k 3.8× 76 0.4× 325 1.8× 165 1.9× 148 1.7× 36 1.8k
Roberto Novati Italy 15 367 1.0× 204 1.1× 186 1.0× 43 0.5× 69 0.8× 24 716
Süleyman Sırrı KILIÇ Türkiye 16 244 0.7× 47 0.3× 54 0.3× 97 1.1× 50 0.6× 62 817
Mustafa Namıduru Türkiye 13 286 0.8× 43 0.2× 98 0.6× 26 0.3× 77 0.9× 54 598
F. Rosmini Italy 13 191 0.5× 81 0.4× 248 1.4× 15 0.2× 14 0.2× 29 974
C. R. Lucas Australia 15 559 1.6× 140 0.8× 403 2.3× 17 0.2× 23 0.3× 35 998

Countries citing papers authored by John W. King

Since Specialization
Citations

This map shows the geographic impact of John W. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. King more than expected).

Fields of papers citing papers by John W. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. King. The network helps show where John W. King may publish in the future.

Co-authorship network of co-authors of John W. King

This figure shows the co-authorship network connecting the top 25 collaborators of John W. King. A scholar is included among the top collaborators of John W. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. King. John W. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hieda, Michinari, et al.. (2020). Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. International Journal of Hepatology. 2020. 1–6. 11 indexed citations
3.
Melia, Michael T., Andrew J. Muir, Jonathan McCone, et al.. (2011). Racial differences in hepatitis C treatment eligibility. Hepatology. 54(1). 70–78. 36 indexed citations
4.
Sulkowski, Mark, Stephen A. Harrison, Lorenzo Rossaro, et al.. (2010). Impaired Fasting Glucose Is Associated With Lower Rates of Sustained Virologic Response (SVR) in Patients With Genotype 1 Chronic Hepatitis C (CHC): Retrospective Analysis of the IDEAL Study. 2 indexed citations
5.
Poordad, Fred, Norbert Bräu, Eric Lawitz, et al.. (2008). Hematologic Safety Data From the IDEAL Trial: Neutropenia, Anemia, and Thrombocytopenia Profiles of Peginterferon alfa/Ribavirin. 1 indexed citations
6.
Berney, S.M., et al.. (2006). Prevalence of Active Hepatitis C Virus Infection in Patients with Systemic Lupus Erythematosus. The American Journal of the Medical Sciences. 331(5). 252–256. 31 indexed citations
7.
Desmond, Chris, et al.. (2004). Using an undertaker's data to assess changing patterns of mortality and their consequences in Swaziland. African Journal of AIDS Research. 3(1). 43–50. 5 indexed citations
8.
Schulman, Joel, et al.. (2003). Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology. 110(2). 437–442. 79 indexed citations
9.
Penn, Robert L., et al.. (2001). Possible Clinically Significant Interaction of Itraconazole Plus Rifampin. AIDS Patient Care and STDs. 15(10). 505–510. 5 indexed citations
10.
Gadallah, Merit F., et al.. (1996). Disparate Prognosis of Thrombotic Microangiopathy in HIV-Infected Patients with and without AIDS. American Journal of Nephrology. 16(5). 446–450. 24 indexed citations
11.
12.
King, John W., et al.. (1990). Comparison of the Immunogenicity of Hepatitis B Vaccine Administered Intradermally and Intramuscularly. Clinical Infectious Diseases. 12(6). 1035–1043. 21 indexed citations
13.
DeVault, George A., John W. King, Michael S. Rohr, et al.. (1990). Opportunistic Infections with Strongyloides stercoralis in Renal Transplantation. Clinical Infectious Diseases. 12(4). 653–671. 103 indexed citations
14.
King, John W., et al.. (1989). Late Dissemination of Pulmonary. CHEST Journal. 95(1). 240–242. 5 indexed citations
15.
Baethge, Bruce A., et al.. (1989). Case report: Herpes Zoster Myelitis Occurring During Treatment for Systemic Lupus Erythematosus. The American Journal of the Medical Sciences. 298(4). 264–266. 11 indexed citations
16.
17.
King, John W., Phi Duong Nguyễn, & Steven A. Conrad. (1988). Results of a Prospective Statewide Reporting System for Infective Endocarditis. The American Journal of the Medical Sciences. 295(6). 517–527. 40 indexed citations
18.
King, John W.. (1980). Cold Agglutinin Disease in a Patient With Legionnaires' Disease. Archives of Internal Medicine. 140(11). 1537–1537. 12 indexed citations
19.
King, John W., et al.. (1955). Frequency of Blood Antigens in a Texas Population Having Mexican Surnames. American Journal of Clinical Pathology. 25(7). 755–760. 1 indexed citations
20.
Collier, Fred C., et al.. (1951). Multiple Myeloma. New England Journal of Medicine. 245(25). 969–971. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Boibieux Breakdown of academic impact, for papers by Olivier Lortholary Breakdown of academic impact, for papers by Kjell B. Hellum Breakdown of academic impact, for papers by John J. Stern Breakdown of academic impact, for papers by Ronald E. Keeney Breakdown of academic impact, for papers by Roberto Novati Breakdown of academic impact, for papers by Süleyman Sırrı KILIÇ Breakdown of academic impact, for papers by Mustafa Namıduru Breakdown of academic impact, for papers by F. Rosmini Breakdown of academic impact, for papers by C. R. Lucas
Rankless by CCL
2026